Daiwa Securities Group Inc. Arcellx, Inc. Transaction History
Daiwa Securities Group Inc.
- $23.7 Billion
- Q1 2025
A detailed history of Daiwa Securities Group Inc. transactions in Arcellx, Inc. stock. As of the latest transaction made, Daiwa Securities Group Inc. holds 178 shares of ACLX stock, worth $12,823. This represents 0.0% of its overall portfolio holdings.
Number of Shares
178
Previous 178
-0.0%
Holding current value
$12,823
Previous $14,000
14.29%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding ACLX
# of Institutions
213Shares Held
48.7MCall Options Held
764KPut Options Held
296K-
Paradigm Biocapital Advisors LP New York, NY4.49MShares$324 Million15.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.99MShares$287 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$270 Million23.3% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$253 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$219 Million4.14% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.16B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...